Logo Logo
Hilfe
Hilfe
Switch Language to English

Scharf, Florentine; Silva, Rafaela Magalhaes Leal; Morak, Monika; Hastie, Alex; Pickl, Julia M. A.; Sendelbach, Kai; Gebhard, Christian; Locher, Melanie; Laner, Andreas; Steinke-Lange, Verena; Koehler, Udo; Holinski-Feder, Elke und Wolf, Dieter A. (2022): Constitutional chromothripsis of the APC locus as a cause of genetic predisposition to colon cancer. In: Journal of Medical Genetics, Bd. 59, Nr. 10: S. 976-983

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Purpose Approximately 20% of patients with clinical familial adenomatous polyposis (FAP) remain unsolved after molecular genetic analysis of the APC and other polyposis genes, suggesting additional pathomechanisms. Methods We applied multidimensional genomic analysis employing chromosomal microarray profiling, optical mapping, long-read genome and RNA sequencing combined with FISH and standard PCR of genomic and complementary DNA to decode a patient with an attenuated FAP that had remained unsolved by Sanger sequencing and multigene panel next-generation sequencing for years. Results We identified a complex 3.9 Mb rearrangement involving 14 fragments from chromosome 5q22.1q22.3 of which three were lost, 1 reinserted into chromosome 5 and 10 inserted into chromosome 10q21.3 in a seemingly random order and orientation thus fulfilling the major criteria of chromothripsis. The rearrangement separates APC promoter 1B from the coding ORF (open reading frame) thus leading to allele-specific downregulation of APC mRNA. The rearrangement also involves three additional genes implicated in the APC-Axin-GSK3B-beta-catenin signalling pathway. Conclusions Based on comprehensive genomic analysis, we propose that constitutional chromothripsis dampening APC expression, possibly modified by additional APC-Axin-GSK3B-beta-catenin pathway disruptions, underlies the patient's clinical phenotype. The combinatorial approach we deployed provides a powerful tool set for deciphering unsolved familial polyposis and potentially other tumour syndromes and monogenic diseases.

Dokument bearbeiten Dokument bearbeiten